Kura Oncology
Social media
Kura Oncology Logo
About Kura Oncology
Kura Oncology Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of personalized therapeutics for the treatment of cancer. The company develops small molecule product candidates targeting genetically defined cancers, including acute leukemias and solid tumors. Its lead candidates include ziftomenib, a menin-KMT2A inhibitor for acute leukemias, and tipifarnib, a farnesyl transferase inhibitor for head and neck squamous cell carcinoma and other cancers. Kura Oncology collaborates with partners to advance precision oncology therapies for patients with high unmet medical needs.
Address
12730 High Bluff Drive, Suite 400
San Diego, 92130
United States
Year founded
2015
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
